Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases
Naeemeh Khalesi, Shahla Korani, Mitra Korani, Thomas P. Johnston, Amirhossein Sahebkar
Topics & Concepts
BortezomibMedicineRheumatoid arthritisProteasome inhibitorChronic inflammatory demyelinating polyneuropathyImmunologyMultiple myelomaImmune systemSystemic lupus erythematosusInternal medicineDiseaseAntibodyMultiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchUbiquitin and proteasome pathways